Perrine Hoet, Vincent Haufroid Exposure to chemical agents can be assessed either by measuring the concentration of the agent in the air by stationary or personal sampling (ambient monitoring), or by measuring some biological variables (biological monitoring). The term biomarker that has been proposed for a few years is used in a broad sense to include almost any measurement reflecting an interaction between a biological system and an environmental agent, which may be chemical, physical, or biological.' However, there is still some debate about the definition of the term and it is clear that interpretation ofthe term varies between authors. Strictly speaking, biological monitoring of exposure to chemical agents means measurement of a substance or its metabolites in various biological media. Sometimes, the concept of biological monitoring is extended to include the detection of early reversible non-adverse effects (biological monitoring of effect). The detection of an adverse effect-for example, increased proteinuria-indicates that exposure is or has been excessive and therefore such a measurement is more logically included in a programme of early detection of health impairment due to industrial chemicals rather than in a biological monitoring programme for evaluating exposure. In view of differences between people in susceptibility to xenobiotics, the detection of increased susceptibility to a chemical hazard might also be considered. This implies the use of biological markers able to detect endogenous aquired or inherent limitation of an organism to respond to a challenge of exposure to a specific xenobiotic substance or a group of such substances (biological monitoring of susceptibility Non-specific methods These tests are used as non-specific indicators of exposure to a group of chemicals-for example, measurement of diazopositive metabolites in urine for monitoring exposure to aromatic amines, the measurement of thioethers in urine to assess exposure to mutagenic and carcinogenic substances, or of the mutagenicity of urine to estimate exposure to such substances. Because of their lack of specificity and the existence of a large individual variability, these tests cannot usually be used to monitor exposure on an individual basis. It is, however, possible that when an adequate control group is used as reference, they may be useful as qualitative tests to identify exposed groups.
Biological monitoring ofeffective dose
These tests directly or indirectly estimate the amount of chemical interacting with the site of action (or toxicologically significant target).
The best known test of this category is the measurement of carboxyhaemoglobin induced by exposure to carbon monoxide (or dichloromethane metabolised into carbon monoxide). However, it should be remembered that exposure to carbon monoxide is certainly not specific to occupational activities and that tobacco smoking is a major source of exposure to carbon monoxide.
Studies in this area have been mainly carried out for exposure to potentially genotoxic substances and for development of the measurement of macromolecular adducts. Protein and DNA adducts can be used as indicators of exposure to reactive substances in the DNA of target tissues. Although the amount of DNA resulting from white blood cells or lymphocytes can be limited, proteins, such as haemoglobin or albumin are present in large quantities in human blood (see biological monitoring of mutagenic or carcinogenic substances). DNA adducts can be removed by DNA repair processes or by cell death, but during chronic exposure they often reach steady state levels in carcinogen target tissues.
BIOLOGICAL MONITORING OF NON-ADVERSE REVERSIBLE EFFECTS
There are many potential biomarkers for assessing the biochemical effects of chemical agents. Schematically, these tests can be divided into two broad categories. The first category includes the variables that indicate pathological damage-such as biomarkers of liver dysfunction (transaminases) or kidney dysfunction (albumin in urine). The second category comprises those detecting early biochemical changes or responses which are considered as reversible and not adverse.
These are often considered to be biomarkers of exposure. Biological effect monitoring has been defined as the measurement of a reversible biochemical change caused by the absorption of the substance; the degree of chance being below that associated with toxic injury and not associated with a known irreversible pathological effect.4 Thus, in this framework, biological monitoring of effects relies on the identification and the measurement of reversible, non-adverse biological effects related to the internal dose. These tests should predict the adverse effects but are to be distinguished from the tests identifying the adverse effects. However, the distinction between adverse and non-adverse biological effects is not always clearcut and is sometimes arbitrary as it may be difficult to evaluate the health significance ofan effect. The inhibition of enzymes-such as the 6-aminolaevulinic acid deshydratase (inhibited by lead) or the pseudocholinesterase (inhibited by organophosphates)-are examples of well validated methods.
The measurement of the activity of numerous enzymes in blood has also been widely used, specially with the development of separation techniques of isoenzymes-for example, lactate dehydrogenase (LDH)-but in these cases they usually indicate adverse effects rather than reversible biochemical changes and are therefore better indicated for early detection of a health impairment programme-for example, the measurement of the hepatic enzymes released into the blood to detect liver damage.
The urinary excretion of numerous proteins, enzymes, and biochemical markers-for example, al and 02-microglobulins, N-acetylglucosaminidase, 0-galactosidase, sialic acid, retinol binding protein, thromboxan, kallikrein-has been investigated by many authors in subjects exposed to nephrotoxic substances such as cadmium, lead, and mercury.5'-0 However, the potential health significance of some of these variables is still unknown. Are they to be considered as reversible non-adverse effects or should they be included in the programme of early detection of health impairment? Mutagenic activity of urine is considered to be among the non-specific tests-for example, mutagenic activity of nurses handling cytostatic drugs.'5 '7 This test shows large variations between people and is prone to interference from smoking, diet, and drugs. Another point to be underlined is that only mutagenic carcinogens can possibly be detected by this method. Moreover, the mutagenic activity measured in urine is not necessarily a reflection of the genetic alteration in the target organ. It should also be stressed that the compound responsible for the mutagenicity in urine may not be involved in the genotoxic effect in the target organ and conversely, the lack of increased mutagenic activity in urine does not necessarily mean the absence of genotoxic lesions.
ANALYSIS OF THIOETHER DETOXIFICATION PRODUCTS IN URINE (SEE NON-SPECIFIC TESTS)
Urinary thioethers are mainly derived from the reaction of electrophilic chemicals with glutathione. The glutathione conjugates formed are then degraded to yield N-acetyl-Salkylcysteine or mercapturic acids which are excreted in the urine. Several authors have evaluated the possibility of measuring urinary excretion of thioethers to detect exposure to electrophilic substances and their precursors -for example, in petroleum retailers, workers occupied in the petoleum industry, in coke ovens, in asphalt producing or using plants, workers exposed to styrene, and workers exposed to pesticides.'"" There are large variations between and within subjects due mainly to the influence of the excretion of endogenous thioethers, diets, and cigarette smoking.2' 24 Moreover, it seems that a value within the normal range does not exclude exposure to an electrophilic substance.25 Therefore, the primary value of this test is its signal function, meaning that when an increase in thioether excretion is found it may be concluded that exposure to such a substance has occurred. DETERMINATION 28 They seem very promising methods but much research is still needed before they can be introduced in the routine biological monitoring of industrial workers.
ANALYSES OF GENOTOXICITY (SEE BIOLOGICAL MONITORING OF EFFECT)
These methods aim to detect the consequences of the interaction of the mutagenic or carcinogenic agent and the genetic material. The various possible methods involve the measurement of chromosomal aberrations, sister chromatid exchanges, unscheduled DNA synthesis, single strand breaks, point mutations, and micronuclei in peripheral blood lymphocytes.29 31 As with mutagenic activity in urine and the measurement of thioethers in urine, because of the wide variations between and within subjects and the many potential confounding factors, these tests can only be used at the group level, to detect a group at risk.
DETECTION OF ONCOGENIC PROTEINS
The identification in urine or plasma of proteins resulting from the activation of an oncogene has been suggested to detect specific mutations. For example, PAHs have been shown to cause specific mutational lesions that can lead to the activation of the ras oncogene and expression of its p21 protein product.32 Much research is still needed before this test can be introduced in the routine biological monitoring of industrial workers.
Main prerequisites for the development of biological markers and their interpretation KNOWLEDGE OF THE TOXICOKINETICS OF THE CHEMICAL
Biological monitoring mainly relies on the knowledge of toxicokinetic data. This includes information on the rate of absorption, distribution, sites of accumulation, biotransformation, and routes of excretion to make the best choice about the substance to be measured as well as the biological media and the time of sampling.
The toxicokinetics of an agent are influenced by many physiological and pathological factors (age, sex, food, drink, smoking, state of health, intake of drugs) that must be taken into account when interpreting a result. For example, chronic intake of ethanol usually stimulates drug metabolising enzymes and hence the biotransformation of other absorbed chemical agents, whereas during or shortly after a large alcohol intake entailing a high concentration of alcohol in the body, there seems to be an inhibitory effect on the metabolism of xenobiotics. 33 Perturbation of renal clearance, or large or restricted beverage intake, may also be responsible for misinterpretation of urinary results (urine samples that are too dilute or too concentrated).
It is also important to underline that physicochemical factors also play an important part in the rate of absorption of a substance. For instance, measurement of nickel in urine is only a qualitative indicator of exposure to soluble nickel compounds but certainly not to insoluble compounds. However, the important health effects caused by exposure to nickel are mainly local (skin, respiratory tract), and the real interest of the dosage of nickel in urine might be questionable.
Practically, the variable most often used to characterise the behaviour of the biological marker in the body is the elimination half lifethat is, the time needed to excrete half the amount of the substance. A substance with a half life of less than two hours is not suitable for monitoring as timing is too critical. When the half life lies between two and 10 hours the optimum sampling time is at the end of the shift or the beginning of the next shift (less influenced by peak exposure). When the substance under investigation has a half life between 10 and 100 hours, it provides an evaluation of the total amount of the chemical absorbed during the preceding day (sampling after 16 hours) or during the week (end ofweek sampling). For cumulative substances-such as heavy metals-the time of sampling is not critical."4 In this case, there is indeed a slow release from a deep compartment that has accumulated the chemical substance over a long period and that may result in an endogenous exposure of target organs-for example, the release of lead from the bones that is increased in some circumstances-such as osteoporosis and bone fracture.
Animal studies can be used to show toxicokinetic patterns of a chemical but confirmatory studies in humans are needed before extrapolation of these patterns from experimental data. Physiologically based pharmacokinetic models taking account of the variability of numerous exposure and physiological factors (intensity and duration of exposure, workload, body build, liver and renal function) may also provide valuable tools when trying to establish relations between external exposure and internal dose.'5
KNOWLEDGE OF THE TOXICODYNAMICS
The knowledge of the non-adverse biological changes and the potential harmful effects should also be considered as a prerequisite for the accurate determination of a tolerable biological action level and the interpretation of the results. The determination of the concentration of the substance at which the effect is expected to occur (dose-effect relation) and the percentage of people showing these effects at each dose level (dose-response relation) are also fundamental data.
In the occupational setting exposure is often to a mixture of substances. This may entail variations in terms of toxicokinetic and toxicodynamic processes, which must be taken into account when interpreting the results (the possible physicochemical interactions between the substances, the effects that one agent may have on the absorption, biotransformation, and excretion of the other).
REFERENCE LEVELS
Results are to be interpreted by comparison with reference limits values.
Reference value observed in an unexposed population The substance under investigation may be present in the biological fluids in the general population without any occupational exposure. These reference values must be derived from a population similar in terms of race, age, sex, and environmental factors-such as air pollution, smoking habits, drugs, and dietary factors. Such an approach is largely used in clinical chemistry and allows identification of exposed people. It needs a sufficiently large sample of the population. Failure to know the main sources of variation limits the validity.
Another limitation is that for some chemicals, the detection limit of the analytical methods available is not sufficiently low to assess the concentration in non-occupationally exposed people.
Biomonitoring action level for an exposed population Biomonitoring action levels allow the uptake of a certain amount of a chemical agent which is considered to be acceptable for the preservation of the health of the subject.
For most substances these levels are derived from the occupational exposure limits in air, and are the concentration of the agent that will occur in the body fluids after an eight hour time weighted average exposure at the occupational exposure limit. Biological monitoring performed under these conditions is much more an assessment of the exposure intensity than of the potential risk to health.
For chemicals that are extensively absorbed through the skin, biological action value based on the relation between the occupational limit value in the air and the concentration in the biological media may underestimate the importance of exposure-for example, glycol ethers.
Ideally the biological action levels should be health based derived from long term follow up studies ofworkers exposed to eight hours a day, five days a week, over a working life without adverse effects. In some situations, a quantitative relation between internal dose and adverse health effect has actually been identified-for instance, for lead in blood, cadmium in urine, or carboxyhaemoglobin. In these cases, the biological variable can be considered as an indicator of health risk. When the internal dose is quantitatively related to both adverse effects and external exposure, the biological variable provides information on both exposure and health risk.
The biological action level may also be derived from good working practices. In this approach, the limit reference is established in comparison with the concentration of the chemical (or its metabolites) found in biological specimens of workers exposed to the substance under investigation when good working practices are adhered to. This approach is largely used, for practical reasons, for substances extensively absorbed through the skin. 
Conclusion

